XPREZA 100MG INJECTION

Form: Injection

Pack Size: 1 VIAL

Marketed by: NATCO PHARMA LTD (ONCOLOGY DIV)

MRP: ₹1979.02

NATCO PHARMA LTD (ONCOLOGY DIV): Xpreza 100MG Injection, 1 vial, salt azacitidine 100mg. NPPA has revised its MRP from Rs 4,005 to Rs 1,979.02 (51% lower) with effect from 09-11-2026; trade rate Rs 1,507.82. Group: hypomethylating agent (chemotherapy). Same salt is also supplied by Dr. Reddy's, Glenmark, Hetero, MSN, Mankind and others. Handling/counselling: injection and tablet forms are not interchangeable; cytotoxic: handle and dispose of as hazardous waste. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.